Authors: BLACK SB SHINEFIELD HR BERGEN R HART C KREMERS R LAVETTER A LEMESURIER J MOROZUMI PA RAY P LEWIS EM FIREMAN B SCHWALBE J HALLAM P SHANDLING M DEKKER C GRANOFF DM IZU A PODDA A

Citation: Sb. Black et al., SAFETY AND IMMUNOGENICITY OF CHIRON BIOCINE(R) RECOMBINANT ACELLULAR PERTUSSIS-DIPHTHERIA-TETANUS VACCINE IN INFANTS AND TODDLERS/, The Pediatric infectious disease journal, 16(1), 1997, pp. 53-58

Authors: STRAUS SE WALD A KOST RG MCKENZIE R LANGENBERG AGM HOHMAN P LEKSTROM J COX E NAKAMURA M SEKULOVICH R IZU A DEKKER C COREY L

Citation: Se. Straus et al., IMMUNOTHERAPY OF RECURRENT GENITAL HERPES WITH RECOMBINANT HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN-D AND GLYCOPROTEIN-B - RESULTS OF A PLACEBO-CONTROLLED VACCINE TRIAL, The Journal of infectious diseases, 176(5), 1997, pp. 1129-1134

Authors: SHEARER WT DULIEGE AM KLINE MW HAMMILL H MINKOFF H AMMANN AJ CHEN S IZU A MORDENTI J

Citation: Wt. Shearer et al., TRANSPORT OF RECOMBINANT HUMAN CD4-IMMUNOGLOBULIN-G ACROSS THE HUMAN PLACENTA - PHARMACOKINETICS AND SAFETY IN 6 MOTHER-INFANT PAIRS IN AIDS CLINICAL-TRIAL GROUP PROTOCOL-146, Clinical and diagnostic laboratory immunology, 2(3), 1995, pp. 281-285

Authors: SCHWARTZ DH GORSE G CLEMENTS ML BELSHE R IZU A DULIEGE AM BERMAN P TWADDELL T STABLEIN D SPOSTO R SILICIANO R MATTHEWS T

Citation: Dh. Schwartz et al., INDUCTION OF HIV-1-NEUTRALIZING AND SYNCYTIUM-INHIBITING ANTIBODIES IN UNINFECTED RECIPIENTS OF HIV-1(IIIB) RGP120-SUBUNIT VACCINE, Lancet, 342(8863), 1993, pp. 69-73